Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with multiple injections of
GAD-Alum will preserve the body's own (endogenous) insulin production in patients who have
been recently diagnosed with type 1 diabetes mellitus (T1DM).
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators:
American Diabetes Association Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Juvenile Diabetes Research Foundation National Center for Research Resources (NCRR) National Institute of Allergy and Infectious Diseases (NIAID)